Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: TPL BK Pacers

c/p from ihub; thanks Neverending!

http://www.munich-innovation.com/

Upon the Effective Date, MIG will assume the role of commercializing the MMP Portfolio, for the benefit of Debtor TPL, Patriot and Mr. Moore himself. The revenue sharing formula set out in the January 23, 2013 Settlement Agreement will continue to serve to divide net MMP proceeds appropriately (among TPL, Patriot and Mr. Moore; Mr. Moore receives and will continue to receive the smallest share). MMP licensing revenues will continue to be channeled through PDS; the PDS chairman will continue to approve and sign off on every license, to assure accountability for licensing proceeds under the same system of safeguards put in place when it was necessary to monitor Mr. Leckrone.

Share
New Message
Please login to post a reply